NanoString Technologies: Litigation-Driven 363 Sale and $392.6M Bruker Acquisition
NanoString filed chapter 11 in Delaware after 10x Genomics patent litigation strained liquidity. Bruker Corporation won the 363 auction at $392.6M, a 78% premium over the $220M stalking horse. The plan confirmed June 2024 with 100% projected GUC recovery.